Medicine and Dentistry
Platelet
100%
Systematic Review
84%
Thrombocyte Function
66%
Bleeding
54%
Thrombocyte Aggregation
48%
Biological Marker
47%
Thrombin
37%
Blood Stasis
36%
Coronary Artery Disease
35%
Fibrinolysis
35%
Cohort Analysis
34%
Malignant Neoplasm
34%
Lung Cancer
33%
Cardiovascular System
31%
Hemostat
31%
Acetylsalicylic Acid
31%
First Trimester Pregnancy
31%
Venous Thromboembolism
30%
Neoplasm
30%
Non Small Cell Lung Cancer
29%
Fibrinogen
29%
Cyanocobalamin
28%
Thrombosis
28%
Meta-Analysis
27%
Blood Clotting
26%
Disease
26%
Macrophage
24%
Antiplatelet
24%
Thromboelastometry
23%
Heart Surgery
23%
Diagnosis
21%
Haemophilia A
20%
Cardiovascular Disease
20%
Randomized Controlled Trial
19%
Cobalamin
18%
Trisomy 21
18%
Cerebral Hemorrhage
18%
Brain Ischemia
17%
Disease Severity
17%
Bladder Cancer
17%
Haemophilia
17%
Thromboembolism
17%
Macrophage Activation
16%
Gene Expression
15%
Hazard Ratio
15%
Placebo
15%
Ex Vivo
15%
Blood Clotting Factor 8
15%
Liver Cirrhosis
15%
Epidermal Growth Factor Receptor
15%
Thrombocyte Activation
15%
Disseminated Intravascular Coagulation
15%
Thrombocytopenia
14%
Liver Disease
14%
Pre-Eclampsia
14%
Tranexamic Acid
14%
Lectin
14%
Symptom
14%
Apoplexy
14%
Fibrosis
13%
Pregnancy-Associated Plasma Protein A
13%
Mannose Receptor
13%
Overall Survival
13%
Pregnancy
13%
Prostate Cancer
13%
Prevalence
13%
Fibrin Clot
12%
Transcobalamin
12%
In Vitro
12%
Light Chain
12%
Diabetes
12%
Circulating Tumor DNA
12%
Sepsis
12%
Antithrombotic
12%
Coagulopathy
11%
microRNA
11%
Von Willebrand Factor
11%
Diabetes Mellitus
11%
C Reactive Protein
11%
Fibrinogen Concentrate
11%
Subarachnoid Hemorrhage
11%
Insulin Dependent Diabetes Mellitus
10%
Recombinant Blood Clotting Factor 7a
10%
Myocardial Infarction
10%
Cross Sectional Study
10%
Drug Therapy
10%
Glucagon Like Peptide 1
10%
Glucose Metabolism
10%
Ciclonicate
9%
Factor VII
9%
Odds Ratio
9%
Neurofilament
9%
Ischemic Preconditioning
9%
Lobectomy
9%
Trefoil Factor
9%
Randomized Clinical Trial
9%
Childbirth
8%
Metastatic Carcinoma
8%
Pediatrics
8%
Maturity Onset Diabetes of the Young
8%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
51%
Bleeding
45%
Acetylsalicylic Acid
44%
Coronary Artery Disease
43%
Inflammation
38%
Disease
35%
Malignant Neoplasm
34%
Neoplasm
34%
Antiplatelet
32%
Vitamin B12
31%
Non Small Cell Lung Cancer
31%
Cohort Study
28%
Venous Thromboembolism
27%
Thrombin
27%
Mannose Receptor
26%
Blood Stasis
24%
Lung Cancer
23%
Anticoagulant Agent
23%
Circulating Tumor DNA
21%
Placebo
21%
Heart Infarction
20%
Epidermal Growth Factor Receptor
20%
Fibrinogen
19%
Haemophilia A
18%
Randomized Controlled Trial
18%
Blood Clotting Factor 8
17%
Brain Ischemia
17%
Pharmacokinetics
17%
Hemostatic Agent
17%
Fibrosis
17%
Overall Survival
16%
Haemophilia
16%
Thromboembolism
16%
Bladder Cancer
16%
Tranexamic Acid
15%
Disease Severity
14%
Cardiovascular Disease
14%
Liver Disease
14%
Receptor
14%
Thrombosis
14%
Disseminated Intravascular Clotting
14%
Nonalcoholic Fatty Liver
13%
Liver Cirrhosis
13%
Von Willebrand Factor
13%
Infection
13%
Thrombocytopenia
12%
Lectin
12%
Ciclonicate
12%
Chronic Hepatitis C
12%
Cytokine
12%
Erlotinib
12%
Randomized Clinical Trial
11%
C Reactive Protein
11%
Progression Free Survival
11%
Vitamin D
11%
Prevalence
11%
Sepsis
11%
Recurrent Disease
11%
Fibrinogen Concentrate
10%
Antivitamin K
10%
Tumor Necrosis Factor
10%
Adverse Event
10%
Subarachnoid Hemorrhage
10%
Insulin Resistance
10%
Direct Oral Anticoagulant
10%
Normal Human
9%
Dexamethasone
9%
Medication Error
9%
Preeclampsia
9%
Cobalamin
9%
Injury
9%
ST Segment Elevation Myocardial Infarction
9%
Von Willebrand Disease
9%
Transcobalamin
9%
Diabetes Mellitus
8%
Non Insulin Dependent Diabetes Mellitus
8%
Blood Clotting Factor
8%
Clopidogrel
8%
Brain Hemorrhage
8%
Symptom
8%
Low Molecular Weight Heparin
8%
Fibrinolytic Agent
8%
Adenosine Diphosphate
8%
Protein Tyrosine Kinase Inhibitor
8%
Cross-Sectional Study
7%
Colorectal Cancer
7%
Comorbidity
7%
Liver Fibrosis
7%
Stent Thrombosis
7%
Clinical Trial
7%
Dabigatran
7%
Insulin Dependent Diabetes Mellitus
6%
Osimertinib
6%
Exendin 4
6%
Binding Protein
6%
Metastatic Colorectal Cancer
6%
Fatty Liver
6%
Mannose Binding Lectin
6%
Anti-Inflammatory Drug
6%
Prothrombin
6%
Biochemistry, Genetics and Molecular Biology
Thrombocyte Aggregation
56%
CD163
47%
Platelet
39%
Cyanocobalamin
37%
Macrophage
35%
Fibrinogen
31%
Epidermal Growth Factor Receptor
31%
Circulating Tumor DNA
29%
Reference Value
29%
Platelet Count
28%
Mannose Receptor
28%
Thrombocyte Function
28%
Thrombin
27%
Blood Level
27%
First Trimester Pregnancy
26%
Macrophage Activation
21%
Monocyte
21%
Cancer Cell
21%
Genotyping
21%
Thrombocyte Activation
20%
Overall Survival
20%
Eicosanoid Receptor
19%
Hemostasis
19%
Trisomy 21
19%
Light Chain
19%
Neurofilament
19%
Coagulation System
18%
Lectin Pathway
17%
MicroRNA
16%
Gene Expression
15%
Fibrinolysis
15%
Thromboelastometry
15%
Cohort Study
15%
Immunoassay
15%
Cardiac Arrest
15%
Messenger RNA
14%
Fibrin Clot
12%
Von Willebrand Factor
12%
Pregnancy-Associated Plasma Protein A
11%
Transcobalamin
11%
Genetics
11%
Droplet Digital Polymerase Chain Reaction
10%
Liquid
10%
Exon
10%
Biochemistry
10%
Insulin Resistance
10%
Monospecific Antibody
10%
Blood Clot Lysis
10%
Genetic Divergence
10%
Tyrosine Kinase Inhibitor
9%
Erlotinib
9%
Glial Fibrillary Acidic Protein
9%
Chromatin Immunoprecipitation
9%
ST Elevation
9%
Randomized Clinical Trial
9%
Biological Variation
9%
Targeted Temperature Management
9%
Enzyme
9%
Flow Cytometry
9%
Real-Time Polymerase Chain Reaction
8%
Allele
8%
Mesenchymal-Epithelial Transition
8%
D-Dimer
8%
Phlebothrombosis
8%
Von Willebrand Disease
8%
Surface Property
8%
Thrombocytopenia
8%
Glucagon-Like Peptide-1
8%
Comorbidity
8%
RNA
8%
Eclampsia
7%
Thrombophilia
7%
Glucose Blood Level
7%
Wild Type
7%
Tumor Volume
7%
Aneuploidy
7%
Single-Nucleotide Polymorphism
7%
Receptor Gene
7%
Progression Free Survival
7%
Hydroxyethyl Starch
7%
Next Generation Sequencing
7%
Coagulopathy
7%
Vitamin D
7%
All Cause Mortality
7%
Agonist
7%
N-Terminus
6%
Bovine Somatotropin
6%
Growth Hormone
6%
Human Immunodeficiency Virus
6%
Platelet Reactivity
6%
Minke Whale
6%
Single Nucleotide Polymorphism
6%
PD-L1
6%
C-Reactive Protein
6%
P-Selectin
6%
Blood Sampling
6%
Metabolic Pathway
6%
Drug Megadose
6%
Low Drug Dose
6%
Ficolin
6%